MDX Research
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract
Role: collaborator
Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)
Role: collaborator
The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting
Role: collaborator
Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
Role: collaborator
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Role: collaborator
Real-world Evidence Study on the Performance and Safety of Halova Ovules
Role: collaborator
Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
Role: collaborator
Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care
Role: collaborator
RWE Study in the Treatment of Cervical Lesions of Various Etiology
Role: collaborator
All 9 trials loaded